MCL-1 dependency of cisplatin-resistant cancer cells

Judith Michels; Florine Obrist; Ilio Vitale; Delphine Lissa; Pauline Garcia; Parviz Behnam‐Motlagh; Kimitoshi Kohno; Gen Sheng Wu; Catherine Brenner; Maria Castedo; Guido Guido Kroemer

doi:10.1016/j.bcp.2014.07.029

Related publications

Article2020

Platinum-AIEgen coordination complex for imaging-guided annihilation of cisplatin-resistant cancer cells

Zhenyan He, Yuting Gao, Haoke Zhang, Xiuxia Wang, Fanling Meng, Liang Luo, Ben Zhong Tang

Article2015

Activation of surrogate death receptor signaling triggers peroxynitrite-dependent execution of cisplatin-resistant cancer cells

S. Seah, Ivan Cherh Chiet Low, Jayshree L. Hirpara, Karishma Sachaphibulkij, Guido Guido Kroemer, Catherine Brenner, Shazib Pervaiz

Article2018

Metabolic vulnerability of cisplatin‐resistant cancers

Florine Obrist, Judith Michels, Sylvère Durand, Alexis Chery, Jonathan Pol, Sarah Lévesque, Adrien Joseph, Valentina Astesana, Federico Pietrocola, Gen Sheng Wu, Maria Castedo, Guido Guido Kroemer

Dataset

Faculty Opinions recommendation of Mcl-1 is essential for the survival of plasma cells.

Stefano Casola, Federica Alberghini

Dataset

Supplementary Table 1 from Lurbinectedin (PM01183), a New DNA Minor Groove Binder, Inhibits Growth of Orthotopic Primary Graft of Cisplatin-Resistant Epithelial Ovarian Cancer

August Vidal, Clara Muñoz, María-José Guillén, Jemina Moretó, Sara Puertas, María Martínez‐Iniesta, Albert Figueras, Laura Padullés, Francisco J. García-Rodríguez, Mireia Berdiel‐Acer, Miguel Ángel Pujana, Ramón Salazar, Marta Gil-Martín, Lola Martí, Jordi Ponce, David G. Mollevı́, Gabriel Capellà, Enric Condom, Francesc Viñals, Dori Huertas, Carmen Cuevas, Manel Esteller,